Crinetics Pharmaceuticals
CRNX
CRNX
94 hedge funds and large institutions have $708M invested in Crinetics Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.22% less ownership
Funds ownership: 87.44% → 87.22% (-0.22%)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
94
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$19.6M | |
| 2 | +$17.9M | |
| 3 | +$12M | |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$6.28M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$6.12M |
Top Sellers
| 1 | -$26M | |
| 2 | -$14.6M | |
| 3 | -$7.16M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.44M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$3.13M |